Key result
An Institute of Medicine study group recommended routine administration of an additional dose of trivalent oral polio vaccine at age 11 to 12 years due to incomplete vaccination in young children.
Why the study?
Is there a need for an additional dose of trivalent oral polio vaccine at age 11 to 12 years in American children?
Is there a need for an additional dose of trivalent oral polio vaccine at age 11 to 12 years in American children?
Discusses the rationale and recommendations for a catch-up dose of oral polio vaccine in preadolescents in the United States.
The introduction and widespread use of the inactivated and live poliovirus vaccines in the United States have brought about a dramatic reduction in the incidence of poliomyelitis: More than 20,000 paralytic cases were reported in 1952, whereas the current annual average is less than 20.1,2As a consequence of this extraordinary degree of control, there is virtually no wild poliovirus circulation in the United States; individual protection from wild virus introduction depends on successful vaccination. Data available in 1976 and 1977 indicated that a substantial proportion (perhaps one third) of American children younger than 5 years had not received a full course of trivalent oral polio vaccine (TOPV).3,4These and other findings led a study group convened by the Institute of Medicine, National Academy of Sciences, to recommend routine administration of an additional dose of TOPV at age 11 to 12 years.5This dose was proposed not
No takes yet. Share an insight, caveat, or question.
Steven G.F. Wassilak (1981) conducted an editorial in Poliomyelitis. Catch-up polio vaccination (TOPV) was evaluated. An Institute of Medicine study group recommended routine administration of an additional dose of trivalent oral polio vaccine at age 11 to 12 years due to incomplete vaccination in young children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: